New Contest Recognizes Heroes in the Fight Against HIVJuly 5, 2011 On June 15, Bristol-Myers Squibb launched the "Atripla: 5 Years, 5 Heroes" contest to mark the fifth anniversary of Atripla by identifying individuals who have made a significant difference in the fight against HIV. According to their press release, "Many individuals help fight HIV in their communities every day, but often do not receive the recognition they deserve. They are the case workers who helped someone through a difficult time, the doctors who taught their patients how to take care of their health, and the family members or friends of people living with HIV who are inspirational." From June 15 through September 2, 2011, individuals can submit a 500-word essay nominating a hero who has made an impact in the fight against HIV within the past five years. An independent panel of judges will select five heroes who will be honored during a dinner in Chicago in November 2011, at the time of the United States Conference on AIDS (USCA). They will also have their stories featured in a video documentary, and receive an all-expense paid trip to New York City in early 2012 for a red carpet screening event. Entrants can either nominate themselves or an individual within their local community. Entries can be submitted online at 5years5heroes.com or by mail at: 5 Years, 5 Heroes Contest Entries must be received by September 2, 2011. For more information on the Atripla: 5 Years, 5 Heroes contest, including official contest rules and entry form, please visit 5years5heroes.com. ![]() June 15: HIV PJA Webinar -- Glass Half Full: Resilience Among Gay Men as an Emerging HIV Prevention Justice Strategy This article was provided by Test Positive Aware Network. Visit TPAN's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|